Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome: Practical lessons from a review

To prevent recurrent ischaemic events, dual antiplatelet therapy (DAPT) is the standard of care after percutaneous coronary intervention and in the treatment of acute coronary syndrome. Recent evidence supports an adjusted DAPT duration in selected patients. The current paper aims to encourage cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: ten Berg, J. M., Zwart, B., van ’t Hof, A. W. J., Liem, A., Waltenberger, J., de Winter, R. J., Jukema, J. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691814/
https://www.ncbi.nlm.nih.gov/pubmed/28762022
http://dx.doi.org/10.1007/s12471-017-1023-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691814/
https://www.ncbi.nlm.nih.gov/pubmed/28762022
http://dx.doi.org/10.1007/s12471-017-1023-y

Ejemplares similares